rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-5-16
|
pubmed:abstractText |
An untreated 66-year-old woman with chronic myelogenous leukaemia (CML) in the chronic phase was initially given imatinib mesylate, rapidly achieving a good cytogenetic response with treatment. However, acute promyelocytic leukaemia complicated by a disseminated intravascular coagulation occurred 9 months after beginning imatinib treatment. Promyelocytic crisis of CML was diagnosed by demonstration of both BCR/ABL and PML/RAR alpha chimeric genes in leukaemic cells by karyotypic and fluorescence in situ hybridization analysis. Clonal evolution with addition of the PML/RAR alpha translocation may have arisen in the early chronic phase of CML, with expansion of this clone during imatinib treatment. Promyelocytic crisis of CML is rare; furthermore, we know of no previous report of promyelocytic crisis occurring during treatment with imatinib.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1421-9662
|
pubmed:author |
pubmed-author:HashiguchiMichitoshiM,
pubmed-author:ImamuraRieR,
pubmed-author:NagataShuichiroS,
pubmed-author:OgataHideakiH,
pubmed-author:OkamuraTakashiT,
pubmed-author:OkuEijiroE,
pubmed-author:OsakiKoichiK,
pubmed-author:OtsuboKorenoriK,
pubmed-author:SataMichioM,
pubmed-author:SekiRitsukoR,
pubmed-author:TakataYukaY,
pubmed-author:YakushijiKazuakiK,
pubmed-author:YoshimotoKohjiK
|
pubmed:copyrightInfo |
2007 S. Karger AG, Basel
|
pubmed:issnType |
Electronic
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
191-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17170522-Aged,
pubmed-meshheading:17170522-Antineoplastic Agents,
pubmed-meshheading:17170522-Flow Cytometry,
pubmed-meshheading:17170522-Humans,
pubmed-meshheading:17170522-Immunophenotyping,
pubmed-meshheading:17170522-In Situ Hybridization, Fluorescence,
pubmed-meshheading:17170522-Karyotyping,
pubmed-meshheading:17170522-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:17170522-Male,
pubmed-meshheading:17170522-Piperazines,
pubmed-meshheading:17170522-Pyrimidines,
pubmed-meshheading:17170522-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2007
|
pubmed:articleTitle |
Promyelocytic crisis of chronic myelogenous leukaemia during imatinib mesylate treatment.
|
pubmed:affiliation |
Division of Haematology, Department of Medicine, Kurume University School of Medicine, Fukuoka, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|